Form 4: AIM ImmunoTech Inc. Executive Acquires Options
SEC Form 4 Filing
Peter W. Rodino III, COO, Secretary, and General Counsel of AIM ImmunoTech Inc., reports acquisition of options.
Summary
- On November 30, 2023, Peter W. Rodino III, the COO, Secretary, and General Counsel of AIM ImmunoTech Inc., acquired 100,000 options with an exercise price of $0.47.
- These options are exercisable from November 30, 2024, and expire on November 30, 2033.
- Following the transaction, Rodino directly owns 100,000 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment. The acquisition of options by an executive is a routine event and doesn't necessarily indicate a strong positive or negative outlook.
Positives
- An executive acquiring options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reporting a change in beneficial ownership by a company insider. It's common for executives to receive stock options as part of their compensation packages.
Stakeholder Impact
- The acquisition of options by an executive could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 11/30/2023 | Date of the options transaction. |
| 11/30/2024 | Date the options become exercisable. |
| 11/30/2033 | Expiration date of the options. |
| 03/27/2024 | Date of signature on the Form 4. |
Keywords
options, derivative securities, Form 4, insider trading, AIM ImmunoTech Inc., Rodino, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.